ABSTRACT
The aim was to present a four-year experience in living related kidney transplantation. A total of 43 patients (9 females and 34 males) were enrolled in this study. The standard triple immunosuppressive therapy (steroids, azathioprine and cyclosporine) was administered in 19 (44.1%) patients, and in 20 (46.5%) mycophenolate mophetil in daily dose of 2 g instead of azathioprine. In 5 (14.2%) patients with high immunological risk and delayed graft function was administered antithymocite globulin in duration of 7-14 days, prophylactically. In 3 (6.97%) patients graft loss was caused by vascular complications and in 1 (2.32%) by infection as the complication. During the first post-transplantation year acute rejection was noticed in 8 (34.7%) patients and in 3 (37.5%) it was steroid resistant. The graft loss was never caused by acute rejection. Six-months graft survival was noticed in 91.1% patients and one-year graft survival in 88.4% patients. One-year patient survival was 100%. Short term results in living related kidney transplantation are excellent and nowadays, due to improvement in immunosuppressive therapy, the success in this type of kidney transplantation is mainly limited by surgical and infective complications.
Subject(s)
Kidney Transplantation , Living Donors , Adult , Female , Follow-Up Studies , Humans , Immunosuppressive Agents/therapeutic use , MaleABSTRACT
The authors present their experience in renal tumour embolization (renal angioinfarction) over a seven-year period (the previous results--1981-1985, are reported). In this period 99 renal angioinfarctions due to malignant renal tumours were observed. Sixty nine renal angioinfarctions were treated preoperatively (before radical nephrectomy), and 30 angioinfarctions were "palliative"--as the only mode of treatment. The authors analyzed the impact of renal angioinfarction before nephrectomy in 69 patients, compared with 57 patients in whom nephrectomy was the only treatment. The obtained results support their previous reports: renal angioinfarction facilitates the operation, minimizes intraoperative blood loss, and probably, prolongs the survival.
Subject(s)
Embolization, Therapeutic , Kidney Neoplasms/therapy , Humans , Kidney Neoplasms/blood supply , NephrectomyABSTRACT
A patient, aged 28, was admitted to the Department of Urology of the Military Medical Academy in Belgrade, for the operation of the right adrenal gland tumour. The adrenal gland tumour was first diagnosed as an inactive hormonal tumour. Intraoperatively it was found in retroperitoneal area, over the right adrenal gland and the right kidney, near the Cava inferior and under the liver it was extirpated. It was a Castleman's tumour of hyaline-vascular type.
Subject(s)
Castleman Disease , Retroperitoneal Neoplasms , Adult , Castleman Disease/pathology , Humans , Male , Retroperitoneal Neoplasms/pathologyABSTRACT
The article describes a patient with primary, closed, calcified renal cyst in whom the first symptoms appeared three years ago. They were manifested as a dull pain in the flank spinal region. A hard painless tumour, of the size of a man's hand, with clearly limited contours, without signs of fluctuation, was palpable in the left paraumbilical region. The intravenous urography revealed the existence of the pyelocaliceal system of the left kidney displaced by a cranially large cyst. The finding was confirmed by ultrasound. Computerized tomography revealed a cyst of 120 x 85 x 70 cm of size. Its wall was calcified and the content liquidus. Renovasography was performed after constatation that renal echinococcus was in question. This procedure enabled a good insight into the distribution of the blood vessels. On the basis of this finding resection of the lower part of the left cystic kidney was performed. The postoperative course was normal. The histologic finding was: Echinococcus cysticus.